Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate

•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM. Activation induc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular immunology 2016-11, Vol.79, p.77-82
Hauptverfasser: Ouadani, Hanen, Ben-Mustapha, Imen, Ben-ali, Meriem, Larguèche, Beya, Jovanic, Tihana, Garcia, Sylvie, Arcangioli, Benoit, Elloumi-Zghal, Houda, Fathallah, Dahmani, Hachicha, Mongia, Masmoudi, Hatem, Rougeon, François, Barbouche, Mohamed-Ridha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 82
container_issue
container_start_page 77
container_title Molecular immunology
container_volume 79
creator Ouadani, Hanen
Ben-Mustapha, Imen
Ben-ali, Meriem
Larguèche, Beya
Jovanic, Tihana
Garcia, Sylvie
Arcangioli, Benoit
Elloumi-Zghal, Houda
Fathallah, Dahmani
Hachicha, Mongia
Masmoudi, Hatem
Rougeon, François
Barbouche, Mohamed-Ridha
description •Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM. Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.
doi_str_mv 10.1016/j.molimm.2016.09.025
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_pasteur_01453058v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161589016302061</els_id><sourcerecordid>1835390707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EokPhDRDysiwSbMdO4g3SqBQy0lRUKqwtx74pHuUP2xlpHoJ3roeULllZts_9PukehN5TklNCy0-HfJh6Nww5S7ecyJww8QJtaF2xTFLOXqJN-qCZqCW5QG9COBBCSlKK1-iCVRUtBRMb9Gdrojvq6KYRu9EuBiw2p-isGwFb0IMbdQA8LFGPEV9td1-yxgVakDs_fcSdnwbcnGbwePdwixmeUxIk0EPUKcH-HXyA0Rmsz0UunnBqum9usfbRdc443eOwtCF6HeEtetXpPsC7p_MS_fx68-O6yfbfv-2ut_vMcF7GTApKiKWWSl5yW4tWGF4D7-qqFK0pidXQUVII28q24HXLJJNQVLZknSjSe3GJsjX3l-7V7N2g_UlN2qlmu1ezDhEWrwjliRb1kSb-auVnP_1eIEQ1uGCg7_UI0xIUrVOoJBWpEspX1PgpBA_dcz4l6ixOHdQqTp3FKSJVEpfGPjw1LO0A9nnon6kEfF4BSHs5OvAqmLTq5Mt5MFHZyf2_4RGVO6tL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835390707</pqid></control><display><type>article</type><title>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ouadani, Hanen ; Ben-Mustapha, Imen ; Ben-ali, Meriem ; Larguèche, Beya ; Jovanic, Tihana ; Garcia, Sylvie ; Arcangioli, Benoit ; Elloumi-Zghal, Houda ; Fathallah, Dahmani ; Hachicha, Mongia ; Masmoudi, Hatem ; Rougeon, François ; Barbouche, Mohamed-Ridha</creator><creatorcontrib>Ouadani, Hanen ; Ben-Mustapha, Imen ; Ben-ali, Meriem ; Larguèche, Beya ; Jovanic, Tihana ; Garcia, Sylvie ; Arcangioli, Benoit ; Elloumi-Zghal, Houda ; Fathallah, Dahmani ; Hachicha, Mongia ; Masmoudi, Hatem ; Rougeon, François ; Barbouche, Mohamed-Ridha</creatorcontrib><description>•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM. Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.</description><identifier>ISSN: 0161-5890</identifier><identifier>EISSN: 1872-9142</identifier><identifier>DOI: 10.1016/j.molimm.2016.09.025</identifier><identifier>PMID: 27716525</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Activation induced cytidine deaminase ; AID mutagenic activity ; Blotting, Western ; Class switch recombination ; Cofactors ; Cytidine Deaminase ; Cytidine Deaminase - genetics ; Humans ; Hyper IgM 2 ; Hyper-IgM Immunodeficiency Syndrome ; Hyper-IgM Immunodeficiency Syndrome - genetics ; Immunoglobulin Class Switching ; Immunoglobulin Class Switching - genetics ; Jurkat Cells ; Life Sciences ; Mutagenesis, Site-Directed ; Mutation ; Somatic hypermutation ; Somatic Hypermutation, Immunoglobulin ; Somatic Hypermutation, Immunoglobulin - genetics</subject><ispartof>Molecular immunology, 2016-11, Vol.79, p.77-82</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</citedby><cites>FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</cites><orcidid>0000-0002-0525-8620 ; 0000-0002-1371-1405 ; 0000-0002-7655-8911</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molimm.2016.09.025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27716525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://riip.hal.science/pasteur-01453058$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Ouadani, Hanen</creatorcontrib><creatorcontrib>Ben-Mustapha, Imen</creatorcontrib><creatorcontrib>Ben-ali, Meriem</creatorcontrib><creatorcontrib>Larguèche, Beya</creatorcontrib><creatorcontrib>Jovanic, Tihana</creatorcontrib><creatorcontrib>Garcia, Sylvie</creatorcontrib><creatorcontrib>Arcangioli, Benoit</creatorcontrib><creatorcontrib>Elloumi-Zghal, Houda</creatorcontrib><creatorcontrib>Fathallah, Dahmani</creatorcontrib><creatorcontrib>Hachicha, Mongia</creatorcontrib><creatorcontrib>Masmoudi, Hatem</creatorcontrib><creatorcontrib>Rougeon, François</creatorcontrib><creatorcontrib>Barbouche, Mohamed-Ridha</creatorcontrib><title>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</title><title>Molecular immunology</title><addtitle>Mol Immunol</addtitle><description>•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM. Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.</description><subject>Activation induced cytidine deaminase</subject><subject>AID mutagenic activity</subject><subject>Blotting, Western</subject><subject>Class switch recombination</subject><subject>Cofactors</subject><subject>Cytidine Deaminase</subject><subject>Cytidine Deaminase - genetics</subject><subject>Humans</subject><subject>Hyper IgM 2</subject><subject>Hyper-IgM Immunodeficiency Syndrome</subject><subject>Hyper-IgM Immunodeficiency Syndrome - genetics</subject><subject>Immunoglobulin Class Switching</subject><subject>Immunoglobulin Class Switching - genetics</subject><subject>Jurkat Cells</subject><subject>Life Sciences</subject><subject>Mutagenesis, Site-Directed</subject><subject>Mutation</subject><subject>Somatic hypermutation</subject><subject>Somatic Hypermutation, Immunoglobulin</subject><subject>Somatic Hypermutation, Immunoglobulin - genetics</subject><issn>0161-5890</issn><issn>1872-9142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAURi0EokPhDRDysiwSbMdO4g3SqBQy0lRUKqwtx74pHuUP2xlpHoJ3roeULllZts_9PukehN5TklNCy0-HfJh6Nww5S7ecyJww8QJtaF2xTFLOXqJN-qCZqCW5QG9COBBCSlKK1-iCVRUtBRMb9Gdrojvq6KYRu9EuBiw2p-isGwFb0IMbdQA8LFGPEV9td1-yxgVakDs_fcSdnwbcnGbwePdwixmeUxIk0EPUKcH-HXyA0Rmsz0UunnBqum9usfbRdc443eOwtCF6HeEtetXpPsC7p_MS_fx68-O6yfbfv-2ut_vMcF7GTApKiKWWSl5yW4tWGF4D7-qqFK0pidXQUVII28q24HXLJJNQVLZknSjSe3GJsjX3l-7V7N2g_UlN2qlmu1ezDhEWrwjliRb1kSb-auVnP_1eIEQ1uGCg7_UI0xIUrVOoJBWpEspX1PgpBA_dcz4l6ixOHdQqTp3FKSJVEpfGPjw1LO0A9nnon6kEfF4BSHs5OvAqmLTq5Mt5MFHZyf2_4RGVO6tL</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Ouadani, Hanen</creator><creator>Ben-Mustapha, Imen</creator><creator>Ben-ali, Meriem</creator><creator>Larguèche, Beya</creator><creator>Jovanic, Tihana</creator><creator>Garcia, Sylvie</creator><creator>Arcangioli, Benoit</creator><creator>Elloumi-Zghal, Houda</creator><creator>Fathallah, Dahmani</creator><creator>Hachicha, Mongia</creator><creator>Masmoudi, Hatem</creator><creator>Rougeon, François</creator><creator>Barbouche, Mohamed-Ridha</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-0525-8620</orcidid><orcidid>https://orcid.org/0000-0002-1371-1405</orcidid><orcidid>https://orcid.org/0000-0002-7655-8911</orcidid></search><sort><creationdate>201611</creationdate><title>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</title><author>Ouadani, Hanen ; Ben-Mustapha, Imen ; Ben-ali, Meriem ; Larguèche, Beya ; Jovanic, Tihana ; Garcia, Sylvie ; Arcangioli, Benoit ; Elloumi-Zghal, Houda ; Fathallah, Dahmani ; Hachicha, Mongia ; Masmoudi, Hatem ; Rougeon, François ; Barbouche, Mohamed-Ridha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-95100d1d19464d85b5c48e4f8765bc60daef1035db9b348b2929e37d62f530353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Activation induced cytidine deaminase</topic><topic>AID mutagenic activity</topic><topic>Blotting, Western</topic><topic>Class switch recombination</topic><topic>Cofactors</topic><topic>Cytidine Deaminase</topic><topic>Cytidine Deaminase - genetics</topic><topic>Humans</topic><topic>Hyper IgM 2</topic><topic>Hyper-IgM Immunodeficiency Syndrome</topic><topic>Hyper-IgM Immunodeficiency Syndrome - genetics</topic><topic>Immunoglobulin Class Switching</topic><topic>Immunoglobulin Class Switching - genetics</topic><topic>Jurkat Cells</topic><topic>Life Sciences</topic><topic>Mutagenesis, Site-Directed</topic><topic>Mutation</topic><topic>Somatic hypermutation</topic><topic>Somatic Hypermutation, Immunoglobulin</topic><topic>Somatic Hypermutation, Immunoglobulin - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ouadani, Hanen</creatorcontrib><creatorcontrib>Ben-Mustapha, Imen</creatorcontrib><creatorcontrib>Ben-ali, Meriem</creatorcontrib><creatorcontrib>Larguèche, Beya</creatorcontrib><creatorcontrib>Jovanic, Tihana</creatorcontrib><creatorcontrib>Garcia, Sylvie</creatorcontrib><creatorcontrib>Arcangioli, Benoit</creatorcontrib><creatorcontrib>Elloumi-Zghal, Houda</creatorcontrib><creatorcontrib>Fathallah, Dahmani</creatorcontrib><creatorcontrib>Hachicha, Mongia</creatorcontrib><creatorcontrib>Masmoudi, Hatem</creatorcontrib><creatorcontrib>Rougeon, François</creatorcontrib><creatorcontrib>Barbouche, Mohamed-Ridha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Molecular immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ouadani, Hanen</au><au>Ben-Mustapha, Imen</au><au>Ben-ali, Meriem</au><au>Larguèche, Beya</au><au>Jovanic, Tihana</au><au>Garcia, Sylvie</au><au>Arcangioli, Benoit</au><au>Elloumi-Zghal, Houda</au><au>Fathallah, Dahmani</au><au>Hachicha, Mongia</au><au>Masmoudi, Hatem</au><au>Rougeon, François</au><au>Barbouche, Mohamed-Ridha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate</atitle><jtitle>Molecular immunology</jtitle><addtitle>Mol Immunol</addtitle><date>2016-11</date><risdate>2016</risdate><volume>79</volume><spage>77</spage><epage>82</epage><pages>77-82</pages><issn>0161-5890</issn><eissn>1872-9142</eissn><abstract>•Stable Jurkat cell line expressing AID-His130Pro was established.•Mutagenic activity of AID-His130Pro mutant was assessed on an artificial substrate.•AID-His130Pro retained a significant mutagenic activity.•The His130 residue is located in a region required for CSR but not for SHM. Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27716525</pmid><doi>10.1016/j.molimm.2016.09.025</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0525-8620</orcidid><orcidid>https://orcid.org/0000-0002-1371-1405</orcidid><orcidid>https://orcid.org/0000-0002-7655-8911</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-5890
ispartof Molecular immunology, 2016-11, Vol.79, p.77-82
issn 0161-5890
1872-9142
language eng
recordid cdi_hal_primary_oai_HAL_pasteur_01453058v1
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Activation induced cytidine deaminase
AID mutagenic activity
Blotting, Western
Class switch recombination
Cofactors
Cytidine Deaminase
Cytidine Deaminase - genetics
Humans
Hyper IgM 2
Hyper-IgM Immunodeficiency Syndrome
Hyper-IgM Immunodeficiency Syndrome - genetics
Immunoglobulin Class Switching
Immunoglobulin Class Switching - genetics
Jurkat Cells
Life Sciences
Mutagenesis, Site-Directed
Mutation
Somatic hypermutation
Somatic Hypermutation, Immunoglobulin
Somatic Hypermutation, Immunoglobulin - genetics
title Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T10%3A46%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20induced%20cytidine%20deaminase%20mutant%20(AID-His130Pro)%20from%20Hyper%20IgM%202%20patient%20retained%20mutagenic%20activity%20on%20SHM%20artificial%20substrate&rft.jtitle=Molecular%20immunology&rft.au=Ouadani,%20Hanen&rft.date=2016-11&rft.volume=79&rft.spage=77&rft.epage=82&rft.pages=77-82&rft.issn=0161-5890&rft.eissn=1872-9142&rft_id=info:doi/10.1016/j.molimm.2016.09.025&rft_dat=%3Cproquest_hal_p%3E1835390707%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835390707&rft_id=info:pmid/27716525&rft_els_id=S0161589016302061&rfr_iscdi=true